IMMUNE-SUPPRESSION AND TUMOR-STROMAL INTERACTION MEDIATED BY GALECTIN-3 IN GASTRIC CANCER - IMPLICATIONS OF NOVEL THERAPEUTIC STRATEGIES
$611,722FY2017Department of the ArmyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center